Recent Top Picks | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Recent Top Picks

Date Signal Company Expert Opinion Price
2017-05-11 TOP PICK iShares-Nasdaq-BioTech-ETF
IBB-Q
Hap (Robert) Sneddon FCSI

All biotech shares are pretty volatile, and there have been some pretty big moves in the last couple of months. He expects this to run up and hit the high of $380, and then run past that. This is a generational change. Good space to be in long-term. 10 years and you should be very happy.

Price:
$291.570
Subject:
TECHNICAL ANALYSIS & MACRO STRATEGY
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-11 TOP PICK Questrade-Russell-1000-Equal-Weight-US-Health-Care-tra
QRH-T
John Hood

He really likes this one.  They cut their fees 50% so this is only 25 basis points.  They took 80 mid cap health care stocks.  He quite likes the structure.

Price:
$21.220
Subject:
OPTIONS & ETFs
Bias:
BULLISH on US MARKET
Owned:
Yes
2017-05-11 TOP PICK Sierra-Wireless
SW-T
Hap (Robert) Sneddon FCSI

He likes the space “the Internet of things” that this is in. This has about 38% of the business in Canada and he thinks it is going to keep growing. It is in the right sector, between the pro-growth and the defensive. They just had a fantastic quarter and caught the street off guard. Sees this having a double from here. The next resistance is around $46, and he thinks it is taking out the $58 at some point. (Analysts’ price target is $29.50.)

Price:
$38.130
Subject:
TECHNICAL ANALYSIS & MACRO STRATEGY
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-11 TOP PICK SPDR-Energy-ETF
XLE-N
John Hood

US energy index ETF.  It is so out of favour now, but there are a number of things that are lining up.  The Saudis want to get the price of oil up because they want to sell off an asset.  He is buying it because it is out of favour and he prefers it to the Canadian energy sector.

Price:
$67.980
Subject:
OPTIONS & ETFs
Bias:
BULLISH on US MARKET
Owned:
Yes
2017-05-11 TOP PICK iShares-S-and-P-TSX-Cap.-Cons.-St.
XST-T
Hap (Robert) Sneddon FCSI

Just had a nice little break out. If you don’t like the ETF, you could look at their top holdings. Good mix long-term. Thinks that a year from now you will be quite happy with this.

Price:
$56.610
Subject:
TECHNICAL ANALYSIS & MACRO STRATEGY
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-11 TOP PICK BMO-Europe-High-Dividend-Covered-Call-Hedged-to-CAD-ET
ZWE-T
John Hood

A play on Europe where he does not have to worry about the Euro or the Pound.

Price:
$22.540
Subject:
OPTIONS & ETFs
Bias:
BULLISH on US MARKET
Owned:
No
2017-05-10 TOP PICK Arris-International-Plc
ARRS-Q
John Burke

This makes Wi-Fi routers, which are in greater and greater demand. Their biggest customer is AT&T (T-N), but they also supply Amazon (AMZN-Q). (Analysts’ price target is $33.50.)

Price:
$28.190
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2017-05-10 TOP PICK Astrazeneca-P-L-C
AZN-N
Paul Macdonald

A diversified pharmaceutical, sort of shifting their business away from traditional fields. They are in decline right now on revenues. You want to be holding this along with Merck and Bristol-Myers. They have a very key study coming out, taking an immuno oncology drug and combining it with another immuno oncology drug. That is going to be a very key catalyst. Dividend yield of 4.5%. (Analysts’ price target is $34.)

Price:
$31.040
Subject:
HEALTHCARE
Bias:
UNKNOWN
Owned:
Yes
2017-05-10 TOP PICK Celgene-Corp
CELG-Q
Paul Macdonald

They are able to double revenues between now and 2020 without a lot of pipeline success. The PEG ratio at .8, is not painful for a lot of their growth. Great financial metrics and you are not paying a lot for it. Some recent volatility presents a decent entry point. (Analysts’ price target is $146.)

Price:
$119.680
Subject:
HEALTHCARE
Bias:
UNKNOWN
Owned:
Yes
2017-05-10 TOP PICK Henkel-AG--and--Co
HENKY-5
John Burke

A consumer products and adhesive company. A few years ago, they acquired Dial soap. It is the 4th largest consumer products company globally. One of their customers is General Motors. Dividend yield of 1.4%.

Price:
$0.000
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2017-05-10 TOP PICK UnitedHealth-Group-Inc
UNH-N
Paul Macdonald

The largest health insurer in the US. There are strong structural tailwinds within the managed care subsector and some potential tax windfalls. They’ve been using their health scripts to win business and reduce costs. Dividend yield of 1.4%. (Analysts’ price target is $191.)

Price:
$173.390
Subject:
HEALTHCARE
Bias:
UNKNOWN
Owned:
Yes
2017-05-10 TOP PICK Wal-Mart-Stores-Inc.
WMT-N
John Burke

You could buy Amazon (AMZN-Q) at 142X earnings, and a lot of risk goes with buying stocks with such a high P/E ratio. Walmart is trading at 17X earnings and gives a dividend of just under 3%. (Analysts’ price target is $74.)

Price:
$76.700
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2017-05-09 TOP PICK Apogee-Enterprises-Inc.
APOG-Q
Jennifer Radman

For the most part, they create the glass you see on buildings, and do the installation. The new CEO is implementing a strategy to create value including good operating efficiencies, starting to do some M&A, and building scale. They shifted to doing higher office towers, which are very cyclical. Now they are looking to penetrate some of the lower, midsize which are a lot more “steady Eddie” and not as cyclical. As they continue to show good execution, the multiple on the stock should expand. Dividend yield of 1%. (Analysts’ price target is $65.)

Price:
$54.250
Subject:
US LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-05-09 TOP PICK Cognizant-Technology-Solutions-Corp.
CTSH-Q
Jennifer Radman

They are on the business technology outsourcing side, for financial services firms, healthcare firms, mostly figuring out how to use technology to make your business better. There were a few headwinds, and those are starting to lapse. They had an activist investor come in, and the board put together a plan to derive value creation, and that is starting to work. She sees quite a few more legs on this. Yield of 1%. (Analysts’ price target is $70.)

Price:
$64.170
Subject:
US LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-05-09 TOP PICK Hudbay-Minerals-Inc.
HBM-T
Lyle Stein

This has fallen from $12 to $7.67. He sold some recently at about $9.50, and is looking for an entry point right about here. The reason for this is zinc. The company is basically zinc/copper 50-50. He likes the near term potential for zinc. When zinc moves, we could be in a situation that is referred to as “the pinch point” where you get a spike up because inventories are so low. Zinc could go to $2, just like met coal went from $90-$300, when inventories get tight. Dividend yield of 0.26%. (Analysts’ price target is $11.)

Price:
$7.700
Subject:
CANADIAN
Bias:
CAUTIOUS
Owned:
Yes
Showing 61 to 75 of 23,910 entries
<< < 3 4 5 6 7 > >>